TP53 and Miyoshi myopathy: Fluorescent in situ hybridization (FISH), the commonest technique used to reveal del(17p), fails to detect, or otherwise underestimates, focal copy number (CN) deletions and/or point mutations affecting TP53, especially when sub-clonal [12], thus preventing an accurate risk stratification of MM.